Ek John Frederick
Chief Financial Officer at GenMark Diagnostics, Inc.
- Sold, on record
- $1.7M
- Dollars the filings state
- Form 4 sales
- 24
- Latest Jan 25, 2021
- Form 144 notices
- 0
- Proposed sales
- Companies
- 1
- Filed as an executive or holder
Companies
- GenMark Diagnostics, Inc.Chief Financial Officer
Sales by reason
Form 4 sales per month, last 12 months.
Timeline
- 1 Form 4 sale GenMark Diagnostics, Inc.UnusualAug 18, 2020 2020
Sold 33,377 shares at $15.98 ($533k)
Ek John Frederick, Chief Financial Officer
Sold 12.6% of holdings ($4.2M position)232,364 shares left27.1x usual sizeFiling
- 2 Form 4 sale GenMark Diagnostics, Inc.Plan not statedAug 20, 2020 +2 days
Sold 2,591 shares at $15.60 ($40k)
Ek John Frederick, Chief Financial Officer
Sold 1.1% of holdings ($3.6M position)229,773 shares left1.8x usual sizeFiling
- 3 Form 4 sale GenMark Diagnostics, Inc.Plan not statedAug 25, 2020 +5 days
Sold 1,515 shares at $14.14 ($21k)
Ek John Frederick, Chief Financial Officer
Sold 0.7% of holdings ($3.2M position)228,258 shares left1.1x usual sizeFiling
- 4 Form 4 sale GenMark Diagnostics, Inc.UnusualSep 16, 2020 +22 days
Sold 5,723 shares at $12.98 ($74k)
Ek John Frederick, Chief Financial Officer
Sold 2.5% of holdings ($3M position)222,535 shares left4x usual sizeFiling
- 5 Form 4 sale GenMark Diagnostics, Inc.UnusualSep 22, 2020 +6 days
Sold 41,196 shares at $13.82 ($569k)
Ek John Frederick, Chief Financial Officer
Sold 18.5% of holdings ($3.1M position)181,339 shares left28.4x usual sizeFiling
- 6 Form 4 sale GenMark Diagnostics, Inc.Plan not statedNov 19, 2020 +58 days
Sold 1,637 shares at $13.85 ($23k)
Ek John Frederick, Chief Financial Officer
Sold 0.9% of holdings ($2.5M position)179,702 shares left1.1x usual sizeFiling
- 7 Form 4 sale GenMark Diagnostics, Inc.Plan not statedNov 24, 2020 +5 days
Sold 1,418 shares at $13.17 ($19k)
Ek John Frederick, Chief Financial Officer
Sold 0.8% of holdings ($2.4M position)178,284 shares left1x usual sizeFiling
- 8 Form 4 sale GenMark Diagnostics, Inc.UnusualJan 25, 2021 +62 days
Sold 18,475 shares at $14.24 ($263k)
Ek John Frederick, Chief Financial Officer
Sold 8.1% of holdings ($3.3M position)210,258 shares left12.7x usual sizeFiling
Every transaction
Loading transactions…
Sales and notices (24)
| Source | |||||||||
|---|---|---|---|---|---|---|---|---|---|
| Jan 25, 2021 | Jan 25, 2021 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 18,475 | $263k | 8.1% | Unusual | SEC |
| Nov 24, 2020 | Nov 25, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 1,418 | $19k | 0.8% | Plan not stated | SEC |
| Nov 19, 2020 | Nov 20, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 1,637 | $23k | 0.9% | Plan not stated | SEC |
| Sep 22, 2020 | Sep 24, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 41,196 | $569k | 18.5% | Unusual | SEC |
| Sep 16, 2020 | Sep 18, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 5,723 | $74k | 2.5% | Unusual | SEC |
| Aug 25, 2020 | Aug 26, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 1,515 | $21k | 0.7% | Plan not stated | SEC |
| Aug 20, 2020 | Aug 24, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 2,591 | $40k | 1.1% | Plan not stated | SEC |
| Aug 18, 2020 | Aug 18, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 33,377 | $533k | 12.6% | Unusual | SEC |
| May 28, 2020 | Jun 1, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 1,460 | $14k | 0.5% | Plan not stated | SEC |
| May 19, 2020 | May 20, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 1,648 | $17k | 0.6% | Plan not stated | SEC |
| Feb 27, 2020 | Feb 28, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 1,040 | $4k | 0.4% | Plan not stated | SEC |
| Feb 25, 2020 | Feb 27, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 516 | $2k | 0.2% | Plan not stated | SEC |
| Feb 20, 2020 | Feb 21, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 8,848 | $34k | 5.1% | Unusual | SEC |
| Jan 21, 2020 | Jan 23, 2020 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 2,753 | $13k | 1.6% | Unusual | SEC |
| Nov 25, 2019 | Nov 26, 2019 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 1,420 | $8k | 0.8% | Plan not stated | SEC |
| Nov 20, 2019 | Nov 21, 2019 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 489 | $3k | 0.3% | Plan not stated | SEC |
| Aug 27, 2019 | Aug 30, 2019 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 1,439 | $9k | 0.8% | Plan not stated | SEC |
| Aug 20, 2019 | Aug 21, 2019 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 510 | $3k | 0.3% | Plan not stated | SEC |
| Aug 5, 2019 | Aug 8, 2019 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 1,890 | $11k | 1.1% | Unusual | SEC |
| May 30, 2019 | May 31, 2019 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 924 | $6k | 0.5% | Plan not stated | SEC |
| May 23, 2019 | May 24, 2019 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 501 | $3k | 0.3% | Plan not stated | SEC |
| May 21, 2019 | May 22, 2019 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 495 | $3k | 0.3% | Plan not stated | SEC |
| Feb 25, 2019 | Feb 27, 2019 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 5,205 | $35k | 2.8% | Plan not stated | SEC |
| Feb 20, 2019 | Feb 21, 2019 | GenMark Diagnostics, Inc. | Chief Financial Officer | Form 4 sale | 595 | $4k | 0.3% | Plan not stated | SEC |